Trade ARMP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Armata Pharmaceuticals, Inc. (ARMP) is trading at US$3.37, up 9.06% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$189.63M. Over the past 52 weeks, ARMP has traded between US$2.75 and US$16.34. On Syfe you can trade ARMP with $0 commission and add it to your watchlist.
| Previous close | US$3.09 |
|---|---|
| Market cap | US$189.63M |
| 52-week range | US$2.75 – US$16.34 |
| Volume | 154.31K |
| Exchange | US |
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.
Year: 1994
Armata Pharmaceuticals' AP-SA02 Gets FDA Breakthrough Therapy Designation
Sep 14, 11:46 AM · MT Newswires
Armata Pharmaceuticals Names David House as CFO; Advances Staphylococcus Aureus Treatment Candidate
Jul 20, 12:51 PM · MT Newswires
Armata Pharma Reaches FDA Agreement on Pediatric Study Plan for AP-SA02
Jul 13, 11:47 AM · MT Newswires
Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday
Jun 23, 1:14 PM · MT Newswires
Armata Pharmaceuticals Receives Additional $2.5 Million in Funding From US Department of Defense
Jun 23, 11:40 AM · MT Newswires
Armata Pharmaceuticals, Inc. (ARMP) stock is trading at US$3.37, +9.06% from the previous close of US$3.09.
The market cap for Armata Pharmaceuticals, Inc. (ARMP) stock is approximately US$189.63M.
The 52-week high for Armata Pharmaceuticals, Inc. (ARMP) stock is US$16.34.
The 52-week low for Armata Pharmaceuticals, Inc. (ARMP) stock is US$2.75.
Armata Pharmaceuticals, Inc. (ARMP) does not currently pay a dividend.
Stay on top of ARMP
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
